The latest announcement is out from Cannara Biotech ( (TSE:LOVE) ).
Cannara Biotech has appointed Justin Cohen to its board of directors as an independent director and a member of the Audit Committee. Cohen, known for his expertise in brand development and digital transformation, is expected to play a crucial role in scaling Cannara’s operations and enhancing its brand presence in Canada. His experience in leading brands through significant growth phases aligns with Cannara’s strategy to position its flagship brands as leaders in the Canadian cannabis market.
More about Cannara Biotech
Cannara Biotech Inc. is a vertically integrated producer of affordable premium-grade cannabis and cannabis-derivative products for the Canadian markets. The company owns two mega facilities in Québec, spanning over 1,650,000 sq. ft., with a potential annualized cultivation output of 100,000 kg. Cannara leverages Québec’s low electricity costs to produce premium-grade cannabis products at an affordable price.
YTD Price Performance: 74.77%
Average Trading Volume: 11,140
Technical Sentiment Signal: Sell
Current Market Cap: $85.34M
Learn more about LOVE stock on TipRanks’ Stock Analysis page.